CN110183527A - A kind of neospora NcMIC26 antigen and its application - Google Patents
A kind of neospora NcMIC26 antigen and its application Download PDFInfo
- Publication number
- CN110183527A CN110183527A CN201910422519.1A CN201910422519A CN110183527A CN 110183527 A CN110183527 A CN 110183527A CN 201910422519 A CN201910422519 A CN 201910422519A CN 110183527 A CN110183527 A CN 110183527A
- Authority
- CN
- China
- Prior art keywords
- neospora
- antigen
- serum
- hole
- pbst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
Abstract
The invention discloses a kind of neospora NcMIC26 antigen and its applications.The present invention discloses a kind of neospora NcMIC26 antigen first, and the amino acid sequence of the antigen is as shown in SEQ ID NO.1.The present invention further discloses the recombinant proteins of above-mentioned antigen to apply in building neospora indirect ELISA diagnostic reagent kit.The present invention has obtained a kind of new diagnostic antigen suitable for neosporosis by screening, indirect ELISA reagent kit is established using its recombinant protein as envelope antigen, it is easy to operate, rapidly and efficiently, specificity is good, sensibility is high, it is reproducible, can be used for detecting cows neospora infections situation, can detect common NcSRS2 Protein Detection less than positive sample, it can get more accurate detection data, be of great significance for the prevention and treatment of neosporosis.
Description
Technical field
The present invention relates to a kind of field of biotechnology, especially with regard to a kind of neospora NcMIC26 antigen and its application.
Background technique
Neosporosis (neosporosis) is a variety of by that can infect caused by neospora (Neospora caninum)
The protozoosis of animal, the disease that neospora causes have global distribution trend.The disease is the most serious to the harm of ox and dog, is
One of cause ox miscarriage, produce the main reason for weak tire, stillborn foetus, the mummification of fetus and the nervous system disorders of dog disease, give herding
Industry brings serious economic loss.The infection intensity for the ox neosporosis that country variant and area are reported exists certain poor
Different, positive rate of antibody is 13.5%~82%.Currently, to neospora, there are no any effective drugs and vaccine.
Neosporosis predominantly detect method have etiological diagnosis, histopathological diagnosis, diagnosis of molecular biology with
And serodiagnosis etc..Since neospora is special sexual cell endoparasitism protozoon, aetology and pathological diagnosis are more difficult, and
Serological diagnostic method can apply to living animal detection, and the zoogenetic infection stage can be provided during epidemiological survey
Information, and its infect neospora after antibody level height, it may be possible to provide about animal with neosporosis, ruminate it is dynamic
The advantages that logistics produces and propagates the information of neospora risk through placenta, it has also become the important hand of epidemiological investigation
Section.The serological technique for being applied to detection neospora antibody earliest is indirect immunofluorescence assay (IFAT), and new at present
" goldstandard " of sporozoite Serology test.But reagent (such as matter of specificity fluorescent labelled antibody that the experiment needs
Amount) and instrument (such as fluorescence microscope) and operating procedure it is complex, it is critical to result to the more demanding of experiment operator
Value is determined with certain difficulty, therefore is not suitable for clinically field high-volume screening experiment.With extensive epidemiology
The development of research, ELISA detection method due to it is simple, quickly, efficiently, as a result determine not influenced etc. by subjective factor it is excellent
It puts and is widely used, be increasingly becoming the main method of Serologic detection.
Early stage indirect ELISA is with the diagnosis of tachyzoite, the neospora antigen of cracking and immunostimulating complex (ISCOM)
Antigen is detected, and shows good Diagnostic parameters during neospora diagnosis, but due to neospora and belong to top
The toxoplasma affiliation of multiple subphylum protozoon is close, is easy to appear cross reaction and causes specificity not high, and prepared by the antigen
Higher cost.With recombinant protein expression and the development of purification technique, native antigen conduct is replaced using high-purity recombinant protein
The diagnostic techniques of detection antigen compensates for disadvantages mentioned above.Generally acknowledged at present is also that most widely used neospora diagnostic antigen is
NcSRS2 shows good specificity and sensibility in Serologic detection.But due to the different times of cattle infected neospora
And there are certain fluctuations in infected cattle body for antibody level.It is found in some researchs, neospora positive babies
The reason of cow serum is negative, and causes this phenomenon may be due to caused by the fluctuation of cow internal antibody level, or
Person is the false negative due to the not high formation of the sensibility of detection method.Reported detection antigen is in the neosporosis to cows
Practical diagnosis during there are still limitation, the result that right pop disease is investigated causes certain error.
Therefore, there is an urgent need to screen the better dominant antigen of new diagnosis effect, more sensitive, special serology is established
Diagnostic method can apply to animal population detection, provide foundation for the diagnosis of neosporosis.
The information disclosed in the background technology section is intended only to increase the understanding to general background of the invention, without answering
When being considered as recognizing or imply that the information constitutes the prior art already known to those of ordinary skill in the art in any form.
Summary of the invention
One of the objects of the present invention is to provide a kind of new neospora dominant antigens, and the antigen is to detection neospora
With high sensibility and good specificity.
Another object of the present invention is to provide include indirect ELISA of the recombinant protein of above-mentioned antigen as envelope antigen
Kit establishes simple, fast and efficient serological diagnostic method.
To achieve the above object, the present invention provides a kind of neospora NcMIC26 antigen, the amino acid sequences of the antigen
Column are as shown in SEQ ID NO.1.
In a preferred embodiment, the present invention prepares the screening of neospora NcMIC26 antigen and identification includes such as
Lower step:
Neospora is cultivated, polypide is proliferated and collects, is incubated for after precipitating is resuspended, tachyzoite excretory-secretory antigen is collected
With tachyzoite whole worm antigen;
The tachyzoite excretory-secretory antigen being collected into and tachyzoite whole worm antigen are subjected to immunoblotting, screening obtain not with
The neospora specific protein band of toxoplasma positive serum reaction;
Neospora specific protein band is collected by SDS-PAGE electrophoresis and is analyzed by mass spectrometry, to obtain this hair
Bright neospora NcMIC26 antigen.
Invention further provides a kind of genes for encoding above-mentioned neospora NcMIC26 antigen.
In a preferred embodiment, the nucleotide sequence of the gene is as shown in SEQ ID NO.2.
The present invention also provides a kind of neospora NcMIC26 antigen above-mentioned or coding neospora NcMIC26 antigens
Gene preparation treatment, diagnosis or prevention of neosporosis product in application.
The present invention further also provides a kind of neospora indirect ELISA diagnostic reagent kit, wraps in the diagnostic kit
Include amino acid sequence recombinant protein rNcMIC26 as shown in SEQ ID NO.1.
In a preferred embodiment, the preparation method of the recombinant protein rNcMIC26 includes the following steps:
1) design primer F and R:
F:5 '-AGCAAATGGGTCGCGGATCCGTTCTGGATTTCATAGACTTGG-3';
R:5 '-TCGAGTGCGGCCGCAAGCTTCGAAGTCCATTCGCCCCACGTT-3';
2) PCR amplification is carried out using primers F and R using the cDNA of neospora as template, obtains target fragment;
3) target fragment and carrier pET-28a are attached, connection product is converted to Escherichia coli Trans1-T1 and is felt
By state cell, recombined pronucleus expression plasmid pET-28a-MIC26 is obtained;
4) the recombined pronucleus expression plasmid pET-28a-MIC26 built is converted to Escherichia coli Transetta and is experienced
State cell induces the expression of recombinant protein, collects and purifies to obtain recombinant protein rNcMIC26.
Neospora indirect ELISA diagnostic reagent kit of the present invention further includes detection antibody, the coating buffer, closing of HRP label
Liquid, antibody diluent, cleaning solution, substrate solution, terminate liquid, neospora positive serum, negative serum.
In a preferred embodiment, the detection antibody of the HRP label is the goat-anti Niu Kangti of HRP label;It is described
Coating buffer is the carbonate buffer solution of the pH=9.6 of 0.05M;The confining liquid is 5% horse serum-PBST;The antibody dilution
Liquid is 2% horse serum-PBST;The cleaning solution is 0.5%PBST;The substrate solution is tmb substrate liquid A, substrate solution B;Institute
Stating terminate liquid is the 2M concentrated sulfuric acid.
The present invention provides the application methods of above-mentioned neospora indirect ELISA diagnostic reagent kit, specifically include following step
It is rapid:
A) recombinant protein rNcMIC26 antigen coat: is diluted to 10 μ with the carbonate buffer solution of the pH=9.6 of 0.05M
G/mL, after coating condition is 37 DEG C of 1h, 4 DEG C of 14~16h of placement;
B) it washs: liquid in hole is discarded, the 0.5%PBST that 300 μ L are added is washed 4 times, every minor tick 5min;
C) close: confining liquid uses 5% horse serum-PBST, every hole 100 μ L, 37 DEG C of closing 1h;
D) wash: operating procedure is same b);
E) primary antibody is incubated for: 2% horse serum-PBST solution 1:200 dilutes ox serum to be checked, every 100 μ L of hole, every plate setting mark
Quasi- ox neospora positive serum, negative serum are as positive negative control;37 DEG C of incubation 1h;
F) wash: operating procedure is same b);
G) secondary antibody is incubated for: being diluted with the goat-anti Niu Kangti 1:25000 of 2% horse serum-PBST solution dilution HRP label, often
Hole 100 μ L, 37 DEG C of incubation 0.5h;
H) wash: operating procedure is same b);
I) develop the color: tmb substrate liquid A, substrate solution B are mixed according to the ratio of 1:1, every 100 μ L of hole, color development at room temperature 10min;
J) terminate: every hole 2M concentrated sulfuric acid terminates reaction, every 50 μ L of hole;Every hole double wave is read in microplate reader after reaction
Long OD450/630nmValue;
H) result judgement: as the OD of serum sample ELISA to be checked450/630nmValue >=0.165 when, can 99.9% level
On be determined as positive findings.
Compared with prior art, it has the following beneficial effects: according to the present invention
The present invention screens to have obtained a kind of new neospora diagnostic antigen, builds using its recombinant protein as envelope antigen
Found indirect ELISA reagent kit, easy to operate, rapidly and efficiently, specificity is good, sensibility is high, and it is reproducible, it can be used for detecting ox
Group's neospora infections situation, can detect common NcSRS2 Protein Detection less than positive sample, can get more accurate
Detection data is of great significance for the prevention and treatment of neosporosis.
Detailed description of the invention
Fig. 1 is the SDS-PAGE figure and Western Blot of neospora secretory protein according to an embodiment of the present invention
Qualification figure;Wherein, 1: tachyzoite excretory-secretory antigen esa;2: tachyzoite whole worm antigen pellet.
Fig. 2 is the amplification figure of MIC26 gene according to an embodiment of the present invention;Wherein, M:DL-2000plus DNA
Marker;1:MIC26 gene amplification product.
Fig. 3 is the protokaryon inducing expression and purifying figure of rNcMIC26-His albumen according to an embodiment of the present invention;Its
In, M: albumen Marker;1: not inducing bacteria liquid sample;2: bacteria liquid sample after induction;3: supernatant protein sample;4: inclusion body protein
Sample;5: rNcMIC26-His albumen after purification.
Fig. 4 is rNcMIC26-His reactionogenicity and specificity identification figure according to an embodiment of the present invention;Wherein, M:
Pre-dyed albumen Marker;1: source of mouse Nc negative serum;2: source of mouse positive serum;3: source of mouse Tg positive serum;4: source of mouse His is mono-
It is anti-.
Specific embodiment
With reference to the accompanying drawing, specific embodiments of the present invention will be described in detail, it is to be understood that guarantor of the invention
Shield range is not limited by the specific implementation.
The experimental method involved in the present invention arrived is conventional method unless otherwise specified.
The materials, reagents and the like used in the following examples is commercially available unless otherwise specified.
Neospora Nc1 (Conrad P A, Barr B C, Sverlow K W, et al.In vitro isolation
and characterization of a Neospora sp.from aborted bovine foetuses[J]
.Parasitology, 1993,106.) public can obtain the biomaterial from applicant, which only attaches most importance to duplicate hair
Used in bright related experiment, it not can be used as other purposes and use.
Bacterial strain: E.coli Transetta (DE3), Trans1-T1 competent cell are purchased from Beijing Quan Shijin biotechnology
Co., Ltd;M5DH5a Competent Cell polymerize U.S. Biotechnology Co., Ltd purchased from Beijing.
Carrier: pET28a prokaryotic expression plasmid, kalamycin resistance start expression fusion His label by T7 promoter
Destination protein.
CDNA reverse transcription reagent box: it is purchased from Beijing Quanshijin Biotechnology Co., Ltd
2 × ExTaq Mix PCR reagent, Goldview nucleic acid dye, DL2000plus DNA marker, reverse transcription examination
Agent box (EasyScript One-step gDNA Removal and cDNA synthesis Supermix): complete purchased from Beijing
Shi Jin Bioisystech Co., Ltd.
His fusion protein purification column (Ni2+), pvdf membrane: it is purchased from Germany Merck Millipore Novagen company.
Low background ECL shines colour reagent box: being century biotechnology Science and Technology Ltd. purchased from Beijing health.
Single slice connects kit: being purchased from Nanjing Nuo Weizan Bioisystech Co., Ltd.
HRP marks goat-anti ox IgG antibody: being purchased from Southern Biotechnology Associates, Inc. (U.S.)
Product.
Specific embodiment is described in detail below, to more fully understand the present invention;It is to be understood that of the invention
Protection scope be not limited by the specific implementation.
Embodiment 1: the screening of neospora diagnostic antigen
1) collection of neospora secretory protein
By neospora Nc1 mass propgation in Vero cell, about 72 hours are bred to state to be released to neospora
When, it separates, purify from Vero cell and collect polypide.Counting reaches 5 × 107A/mL or more, with 200 μ L serum-free DMEM
Precipitating, 37 DEG C of incubation 3-5h are resuspended;With centrifugation after the completion of being incubated for, neospora secretory protein is respectively obtained, i.e., extracellular speed
Grow sub- excretory-secretory antigen (esa) and tachyzoite whole worm antigen (pellet);To the secretory protein being collected into, SDS-PAGE is carried out
Electrophoresis carries out silver staining according to silver staining kit specification, as a result such as Fig. 1.
2) the Western Blot identification of neospora secretory protein
The secretory protein being collected into using Western blot method to the above method carries out antigen-reactive originality and special
Property identification, primary antibody be source of mouse neospora positive serum, rabbit source toxoplasma positive serum, secondary antibody be HRP label sheep anti mouse
The goat anti-rabbit igg of IgG, HRP label;As a result as shown in Figure 1, having filtered out the neospora not reacted with toxoplasma positive serum
The protein band (50~70kDa) of specificity.
3) Mass Spectrometric Identification of neospora specific proteins
According to Western blot as a result, specific band (50~70kDa) corresponding in SDS-PAGE protein adhesive is cut,
It send to BeiJing HuaDa protein Research Center Co., Ltd's mass spectral analysis, corresponding polypeptide information is obtained, in conjunction with bioinformatics
The immunogenicity of albumen is analyzed, the immunogenicity of each antigen gene of comprehensive analysis determines that screening neospora dominant antigen is
NcMIC26, the amino acid sequence as shown in SEQ ID NO.1.
Embodiment 2: the protokaryon inducing expression and purifying of recombinant protein r NcMIC26
1) clone of NcMIC26 gene
According to the neospora dominant antigen NcMIC26 known in embodiment 1, ToxoDB online database (http: //
Www.toxodb.org the coding gene sequence that neospora NcMIC26 antigen is found in) removes its signal peptide, selection and bow
The shape lower part of worm homologous gene similitude (271bp-1014bp), design primer F and R, using the cDNA of neospora as mould
Plate expands the genetic fragment of neospora MIC26, and the nucleotide sequence of the genetic fragment is such as tied as shown in SEQ ID NO.2
Fruit is as shown in figure 3, sequence size is 744bp;
Wherein, the cDNA of neospora extracts neospora RNA and reverse transcription by Trizol- chloroform method, specifically includes
Following steps:
The neospora tachyzoite of purifying is collected up to 3~5 × 107It is a, use 1mLRNA separation agent is resuspended equal
It is even, it is stored at room temperature 10min;200 μ L chloroforms are added, vortex oscillation 20s is stored at room temperature 5min, 4 DEG C of centrifugation 12000rpm centrifugations
15min;Sample is transferred in new EP pipe after centrifugation, the isopropanol of isometric -80 DEG C of pre-coolings of addition, it is quiet in -20 DEG C of refrigerators
15min is set, rear 4 DEG C of centrifugation 12000rpm are centrifuged 15min;Supernatant is abandoned, 75% ethyl alcohol 1mL of -20 DEG C of pre-coolings is added, it is heavy slowly to have hanged
It forms sediment, 4 DEG C of centrifugation 12000rpm are centrifuged 15min;This step is repeated, supernatant is discarded.Completely to ethyl alcohol volatilization, add the DEPC of 15 μ L or so
Water dissolution precipitating, as extracts and obtains RNA.
Using cDNA reverse transcription reagent box, reverse transcription is carried out according to the reaction system of table 1 and obtains the cDNA of neospora.
1 neospora RNA reverse transcription of table at cDNA reaction system
Primer are as follows:
F:5 '-AGCAAATGGGTCGCGGATCCGTTCTGGATTTCATAGACTTGG-3 ' (as shown in SEQ ID NO.3)
Restriction enzyme site containing BamHI (underscore mark),
R:5 '-TCGAGTGCGGCCGCAAGCTTCGAAGTCCATTCGCCCCACGTT-3 ' (as shown in SEQ ID NO.4)
Restriction enzyme site containing HindIII (underscore mark);
Reaction system are as follows: 1 μ L, 2 × ExTaq Mix PCR polymerase of 1 μ L of template cDNA, primers F 1 μ L, primer R, 25 μ
L, DDH222 μ L of O, totally 50 μ L system;
PCR reaction process are as follows: 95 DEG C of initial denaturations 5min, 95 DEG C of denaturation 30s, 57 DEG C of annealing 1min, 72 DEG C of extension 1min, if
Set 35 circulations, 72 DEG C of last extension 10min;PCR product is obtained after nucleic acid electrophoresis using plastic recovery kit recycling PCR
Target fragment, be placed in -20 DEG C of preservations.
2) building of recombined pronucleus expression plasmid pET-28a-MIC26 and protein expression
Using single slice connection kit by after purification neospora MIC26 genetic fragment and pET-28a double digestion bone
Frame carries out single slice connection (reaction system are as follows: 3 μ L, MIC26 genetic fragment of pET-28a double digestion carrier framework 4 μ L, 5 × CE
21 μ L of μ L, Exnase of Buffer, totally 10 μ L);Connection product is converted into Escherichia coli Trans1-T1 competent cell,
Appropriate bacterium solution is taken to be inoculated into the LB solid medium of that resistance of card, inversion is incubated overnight;It selects single bacterium colony and carries out PCR mirror
It is fixed, positive bacterium solution sequencing is selected, recombined pronucleus expression plasmid pET-28a-MIC26 is obtained.
The recombined pronucleus expression plasmid pET-28a-MIC26 built is converted to Escherichia coli Transetta competence
In cell, PCR is accredited as positive monoclonal bacterium and expands culture, 0.8mM IPTG in the LB liquid medium of that resistance of card
Induce the expression of recombinant protein.
Collect thallus, ice-bath ultrasonic cracking, 4 DEG C of centrifuge separation supernatant inclusion body proteins, SDS-PAGE electrophoretic analysis weight
The expression-form of histone, as a result as shown in Figure 3, it is known that recombinant protein rNcMIC26 is mainly expressed in inclusion body, to forgiving
Recombinant protein is purified in nickel affinity chromatography method after carrying out renaturation after body washing;SDS-PAGE analyzes purity of protein, knot
As shown in Figure 3, obtained recombinant protein rNcMIC26-His size after purification is 35kDa to fruit, -80 after the albumen packing of purifying
It DEG C saves backup.
3) rNcMIC26-His reactionogenicity and specificity identification
Reactionogenicity identification is carried out to recombinant protein rNcMIC26-His using Western Blot, concrete operations: respectively
With source of mouse neospora positive serum (1:400), source of mouse neospora negative serum (1:400), source of mouse toxoplasma positive serum
(1:400), source of mouse His monoclonal antibody (1:500 is served only for the recombinant protein with His label) are incubated for as primary antibody;Secondary antibody makes
Western blot test is carried out with corresponding HRP label mountain sheep anti-mouse igg (1:5000) antibody;As a result as shown in figure 4, illustrating weight
Histone rNcMIC26-His has sound response originality, determine the recombinant protein rNcMIC26-His of the neospora not with bow
There are cross reaction, the preliminary assessment albumen to have the diagnostic value of neosporosis for shape worm.
Embodiment 3: the foundation of cow's serum neospora antibody indirect ELISA detection method
1) reaction condition
Cow's serum neospora antibody indirect ELISA reaction condition is as shown in table 2:
2 cow's serum neospora antibody indirect ELISA reaction condition of table
Method and step is as follows:
A) recombinant protein rNcMIC26 antigen coat: is diluted to 10 μ with the carbonate buffer solution of the pH=9.6 of 0.05M
G/mL, every 100 μ L of hole in 96 hole enzyme mark micro-reaction plates, after coating condition is 37 DEG C of 1h, 4 DEG C overnight (14~16h);
B) it washs: liquid in hole is discarded, the 0.5%PBST that 300 μ L are added is washed 4 times, every minor tick 5min;
C) close: confining liquid uses 5% horse serum-PBST, every hole 100 μ L, 37 DEG C of closing 1h;
D) wash: operating procedure is same b);
E) primary antibody is incubated for: 2% horse serum-PBST solution 1:200 dilutes ox serum to be checked, every 100 μ L of hole, every plate setting mark
Quasi- ox neospora positive serum, negative serum are as positive negative control;37 DEG C of incubation 1h;
F) wash: operating procedure is same b);
G) secondary antibody is incubated for: being diluted with the goat-anti Niu Kangti 1:25000 of 2% horse serum-PBST solution dilution HRP label, often
Hole 100 μ L, 37 DEG C of incubation 0.5h;
H) wash: operating procedure is same b);
I) develop the color: tmb substrate liquid A, substrate solution B are mixed according to the ratio of 1:1, every 100 μ L of hole, color development at room temperature 10min;
J) terminate: every hole 2M concentrated sulfuric acid terminates reaction, every 50 μ L of hole;Every hole double wave is read in microplate reader after reaction
Long OD450/630nmValue.
2) determination of ELISA detection method critical value
RNcMIC26-ELISA detects 30 parts of ox neospora negative antibody serum OD450/630nmValue as shown in table 3, obtains
Average valueIt is 0.065, standard deviation (SD) is 0.033, critical valueIt is 0.165, according to principle of statistics, when
The OD of serum sample ELISA to be checked450/630nmWhen value >=0.165, it can be determined as positive findings in 99.9% level.
The determination of 3 rNcMIC26-ELISA critical value of table
3) sensitivity experiment
By standard positive serum sample, doubling dilution, progress ELISA experiment determine serum most with critical value since 1:50
High dilution;The results are shown in Table 4, and the indirect ELISA method after optimization can detecte serum highest dilution and reach 1:3200,
Illustrate that the sensitivity of this method detection is higher.
4 rNcMIC26-ELISA sensitivity experiment result of table
4) cross reaction is tested
Cross reaction test is carried out with toxoplasma, obtains that the results are shown in Table 5, shows that this method detection ox toxoplasma is positive
The OD value of serum is respectively less than its critical value, illustrates that built rNcMIC26-ELISA is neospora antibody specificity indirect ELISA
Detection method can distinguish ox arch insect infection during diagnosing to neosporosis.
5 rNcMIC26-ELISA specificity experiments result of table
5) repeated experiment
Test result is repeated in batch and between criticizing as shown in table 6, table 7, the coefficient of variation of all comparative samples is respectively less than 15%,
Illustrate this method repeatability preferably.
Experimental result is repeated in 6 rNcMIC26-ELISA of table batches
Experimental result is repeated between 7 rNcMIC26-ELISA of table batches
6) comparative experiments
Detect that 98 parts of neosporas are positive and 39 parts of neospora feminine gender cow's serums with IFAT, respectively with MIC26 and
The indirect ELISA that two kinds of antigen of SRS2 is established is detected, and the specificity and sensibility of ELISA are compared;The results are shown in Table 8,
Compared with IFAT, rNcMIC26-ELISA sensibility is 76.53% (75/98) compared with SRS2 high, and specificity is 84.62% (33/
39), two kinds of albumen diagnosis effects are close;During being detected to 98 parts of neospora positive serums, rNcMIC26-
The serum of ELISA test positive has 75 parts, and the serum of rSRS2-ELISA test positive has 65 parts, the positive findings of the two
And it is non-uniform;It is for statistical analysis to totally 137 parts of serum of detection, by after the association of two kinds of diagnostic antigens its with
IFAT positive coincidence rate is 93.88% (92/98), and negative match-rate is still 84.62% (33/39).
The different antigen coat indirect ELISAs of table 8 are compared with IFAT coincidence rate
Therefore, the neospora diagnostic antigen sensibility screened in the present invention is good, and specificity is high, can be used as and generally acknowledges at present
It is pure and fresh to can be applied to ox blood for one supplement antigen of diagnostic antigen SRS2 missing inspection, the sensibility of the detection improved to a greater extent
The detection of sporozoite antibody, confidence level are higher.
The aforementioned description to specific exemplary embodiment of the invention is in order to illustrate and illustration purpose.These descriptions
It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed
And variation.The purpose of selecting and describing the exemplary embodiment is that explaining specific principle of the invention and its actually answering
With so that those skilled in the art can be realized and utilize a variety of different exemplary implementation schemes of the invention and
Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.
Sequence table
<110>China Agricultural University
<120>a kind of neospora NcMIC26 antigen and its application
<130> P190459DD1F
<141> 2019-05-22
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 248
<212> PRT
<213>artificial sequence (Artificial Sequence)
<400> 1
Val Leu Asp Phe Ile Asp Leu Val Pro Ile Ser Ser Glu Glu Val His
1 5 10 15
Leu Ser Val Val Thr Phe Ala Asp Ser Pro Gln Asp Val Phe Thr Phe
20 25 30
Lys Gln Pro Gln Ala Thr Asn Lys Gln Leu Ala Lys Glu Ala Phe Lys
35 40 45
Tyr Leu Arg Tyr Arg Arg Gly Gly Ser Thr Ala Thr Asp Lys Gly Leu
50 55 60
Ile Arg Ala Arg Arg Tyr Leu Thr Arg Pro Val Tyr Gly Thr Arg Ala
65 70 75 80
Asn Val Pro Lys Val Leu Val Leu Met Thr Asp Gly Glu Ser Asp Arg
85 90 95
His Tyr Asp Thr Ile Gln Ala Ala Asp Gln Ala Arg Ala Glu Gly Ile
100 105 110
Ser Val Phe Val Val Gly Val Gly Met Ala Asn Pro Val Glu Cys Arg
115 120 125
Gly Val Cys Gly Cys Gly Arg Tyr Gly Pro Cys Pro Gln Phe Ile Met
130 135 140
Ser Asn Trp Asn Glu Leu Val Gln Thr Val Asp Ser Ile Met Gly Glu
145 150 155 160
Val Cys Lys Lys Leu Pro Lys Asp Ala Glu Cys Ser Glu Trp Ser Glu
165 170 175
Trp Ser Gly Cys Thr Ala Ser Cys Gly Ala Gly Thr Arg Thr Lys Thr
180 185 190
Arg Lys Gln Leu Ser Pro Pro Leu Ala Gly Asp Pro Pro Cys Asp Asn
195 200 205
Cys Glu Pro Met Met Gly Lys Thr Cys Glu Asp Leu Gly Gly Leu Val
210 215 220
Arg Val Glu Asp Cys Asn Gln Gly Glu Cys Pro Gln Asp Ala Gly Cys
225 230 235 240
Gly Thr Trp Gly Glu Trp Thr Ser
245
<210> 2
<211> 744
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 2
gttctggatt tcatagactt ggttcccatc tcctctgaag aggttcacct ttcggtggtg 60
accttcgcgg actcaccgca ggacgtcttc actttcaagc aacctcaggc aaccaacaag 120
caactggcga aagaagcatt taaatacctg agataccgga gggggggaag tacggcgacg 180
gacaaaggcc ttatacgcgc acgccgatac ctcacccgcc ccgtgtatgg cacgcgagcg 240
aacgtaccga aggtgctggt gctcatgaca gatggcgaat cggacaggca ttacgacacc 300
atccaagctg cggaccaagc aagagctgag ggcatttcgg ttttcgttgt tggcgttgga 360
atggccaacc ctgtagagtg ccgtggtgtc tgtgggtgcg ggaggtacgg cccttgtccg 420
cagtttatca tgtccaactg gaacgaactg gtacaaactg tcgattcgat tatgggtgaa 480
gtgtgcaaga aattgcccaa agatgcagag tgcagcgagt ggagcgaatg gtcggggtgc 540
acagcctctt gtggcgccgg cacgcgcacc aaaactcgga agcaactgtc cccgccgctg 600
gctggagatc ccccatgcga caactgcgag ccgatgatgg gcaaaacgtg tgaagatctt 660
ggaggtcttg tgagggttga ggattgcaac cagggcgagt gcccccagga cgccggctgt 720
ggaacgtggg gcgaatggac ttcg 744
<210> 3
<211> 42
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 3
agcaaatggg tcgcggatcc gttctggatt tcatagactt gg 42
<210> 4
<211> 42
<212> DNA
<213>artificial sequence (Artificial Sequence)
<400> 4
tcgagtgcgg ccgcaagctt cgaagtccat tcgccccacg tt 42
Claims (10)
1. a kind of neospora NcMIC26 antigen, which is characterized in that the amino acid sequence of the antigen such as SEQ ID NO.1 institute
Show.
2. a kind of gene for encoding neospora NcMIC26 antigen described in claim 1.
3. gene according to claim 2, which is characterized in that the nucleotide sequence of the gene such as SEQ ID NO.2 institute
Show.
4. a kind of neospora NcMIC26 antigen as described in claim 1 is in preparation treatment, diagnosis or prevention of neosporosis
Product in application.
5. a kind of gene as claimed in claim 2 or claim 3 answering in the product of preparation treatment, diagnosis or prevention of neosporosis
With.
6. a kind of neospora indirect ELISA diagnostic reagent kit, which is characterized in that include amino acid sequence in the diagnostic kit
Arrange the recombinant protein rNcMIC26 as shown in SEQID NO.1.
7. neospora indirect ELISA diagnostic reagent kit according to claim 6, which is characterized in that the recombinant protein
The preparation method of rNcMIC26 includes the following steps:
1) design primer F and R:
F:5 '-AGCAAATGGGTCGCGGATCCGTTCTGGATTTCATAGACTTGG-3';
R:5 '-TCGAGTGCGGCCGCAAGCTTCGAAGTCCATTCGCCCCACGTT-3';
2) PCR amplification is carried out using primers F and R using the cDNA of neospora as template, obtains target fragment;
3) target fragment and carrier pET-28a are attached, connection product is converted to Escherichia coli Trans1-T1 competence
Cell obtains recombined pronucleus expression plasmid pET-28a-MIC26;
4) the recombined pronucleus expression plasmid pET-28a-MIC26 built is converted thin to Escherichia coli Transetta competence
Born of the same parents induce the expression of recombinant protein, collect and purify to obtain recombinant protein rNcMIC26.
8. neospora indirect ELISA diagnostic reagent kit according to claim 6, which is characterized in that the kit is also
Detection antibody, coating buffer, confining liquid, antibody diluent, cleaning solution, substrate solution, terminate liquid, new spore including HRP label
Worm positive serum, negative serum.
9. neospora indirect ELISA diagnostic reagent kit according to claim 8, which is characterized in that the HRP label
Detect the goat-anti Niu Kangti that antibody is HRP label;The coating buffer is the carbonate buffer solution of the pH=9.6 of 0.05M;The envelope
Closing liquid is 5% horse serum-PBST;The antibody diluent is 2% horse serum-PBST;The cleaning solution is 0.5%PBST;Institute
Stating substrate solution is tmb substrate liquid A, substrate solution B;The terminate liquid is the 2M concentrated sulfuric acid.
10. a kind of application method of the neospora indirect ELISA diagnostic reagent kit as described in claim 6-9 is any, special
Sign is, includes the following steps:
A) antigen coat: being diluted to 10 μ g/mL with the carbonate buffer solution of the pH=9.6 of 0.05M for recombinant protein rNcMIC26,
After coating condition is 37 DEG C of 1h, 4 DEG C of 14~16h of placement;
B) it washs: liquid in hole is discarded, the 0.5%PBST that 300 μ L are added is washed 4 times, every minor tick 5min;
C) close: confining liquid uses 5% horse serum-PBST, every hole 100 μ L, 37 DEG C of closing 1h;
D) wash: operating procedure is same b);
E) primary antibody is incubated for: 2% horse serum-PBST solution 1:200 dilutes ox serum to be checked, every 100 μ L of hole, and standard ox is arranged in every plate
Neospora positive serum, negative serum are as positive negative control;37 DEG C of incubation 1h;
F) wash: operating procedure is same b);
G) secondary antibody is incubated for: being diluted with the goat-anti Niu Kangti 1:25000 of 2% horse serum-PBST solution dilution HRP label, every hole 100
μ L, 37 DEG C of incubation 0.5h;
H) wash: operating procedure is same b);
I) develop the color: tmb substrate liquid A, substrate solution B are mixed according to the ratio of 1:1, every 100 μ L of hole, color development at room temperature 10min;
J) terminate: every hole 2M concentrated sulfuric acid terminates reaction, every 50 μ L of hole;Every hole dual wavelength is read in microplate reader after reaction
OD450/630nmValue;
H) result judgement: as the OD of serum sample ELISA to be checked450/630nmWhen value >=0.165, it can sentence in 99.9% level
It is set to positive findings.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910422519.1A CN110183527B (en) | 2019-05-21 | 2019-05-21 | Neosporozoan NcMIC26 antigen and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910422519.1A CN110183527B (en) | 2019-05-21 | 2019-05-21 | Neosporozoan NcMIC26 antigen and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110183527A true CN110183527A (en) | 2019-08-30 |
CN110183527B CN110183527B (en) | 2021-03-12 |
Family
ID=67717126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910422519.1A Expired - Fee Related CN110183527B (en) | 2019-05-21 | 2019-05-21 | Neosporozoan NcMIC26 antigen and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110183527B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110938127A (en) * | 2019-12-17 | 2020-03-31 | 河南科技大学 | Sarcocystis miers antigen, coding gene, recombinant antigen, indirect ELISA antibody detection kit and application thereof |
CN110981969A (en) * | 2019-12-24 | 2020-04-10 | 长江大学 | ALV-K ELISA kit and detection method thereof |
CN113214374A (en) * | 2020-02-06 | 2021-08-06 | 深圳华大基因股份有限公司 | Echinococcosis new antigen Cystatin protein |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1232087A (en) * | 1998-03-26 | 1999-10-20 | 辉瑞产品公司 | Polynucleotide molecules encoding neospora proteins |
CN104812403A (en) * | 2012-08-02 | 2015-07-29 | 维塔姆费罗公司 | Use of attenuated strains of parasites for the prevention or treatment of pathologies associated with an apicomplexan |
WO2017072325A1 (en) * | 2015-10-28 | 2017-05-04 | Universidad Complutense De Madrid | Neospora vaccine composition |
CN106970210A (en) * | 2017-02-22 | 2017-07-21 | 中国农业科学院上海兽医研究所 | A kind of toxoplasmosis indirect ELISA diagnostic reagent kit |
-
2019
- 2019-05-21 CN CN201910422519.1A patent/CN110183527B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1232087A (en) * | 1998-03-26 | 1999-10-20 | 辉瑞产品公司 | Polynucleotide molecules encoding neospora proteins |
CN104812403A (en) * | 2012-08-02 | 2015-07-29 | 维塔姆费罗公司 | Use of attenuated strains of parasites for the prevention or treatment of pathologies associated with an apicomplexan |
WO2017072325A1 (en) * | 2015-10-28 | 2017-05-04 | Universidad Complutense De Madrid | Neospora vaccine composition |
CN106970210A (en) * | 2017-02-22 | 2017-07-21 | 中国农业科学院上海兽医研究所 | A kind of toxoplasmosis indirect ELISA diagnostic reagent kit |
Non-Patent Citations (1)
Title |
---|
无: "XM_003883565.1", 《GENBANK》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110938127A (en) * | 2019-12-17 | 2020-03-31 | 河南科技大学 | Sarcocystis miers antigen, coding gene, recombinant antigen, indirect ELISA antibody detection kit and application thereof |
CN110981969A (en) * | 2019-12-24 | 2020-04-10 | 长江大学 | ALV-K ELISA kit and detection method thereof |
CN113214374A (en) * | 2020-02-06 | 2021-08-06 | 深圳华大基因股份有限公司 | Echinococcosis new antigen Cystatin protein |
Also Published As
Publication number | Publication date |
---|---|
CN110183527B (en) | 2021-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111978378B (en) | SARS-CoV-2 antigen polypeptide and its application | |
CN110183527A (en) | A kind of neospora NcMIC26 antigen and its application | |
WO2005016132A2 (en) | Diagnostics for sars virus | |
US20240108719A1 (en) | Allergy antigen and epitope thereof | |
CN1045603A (en) | Screening system | |
CN111647055B (en) | N protein for detecting novel coronavirus, preparation and application thereof | |
CN114736290B (en) | Nanometer antibody capable of recognizing porcine pseudorabies virus with high accuracy and sensitivity, preparation method and application | |
AU658890B2 (en) | Method for detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto | |
CN110568178A (en) | Zika virus NS1 antigen and application thereof in preparation of fluorescent immunochromatography reagent | |
CN103917874B (en) | The vaccine diagnosis improved | |
CN104845981B (en) | Babesiamicrofti Bm1524 antigens and its application | |
CN111548423B (en) | Mycoplasma pneumoniae fusion antigen and preparation method and application thereof | |
CN108893476B (en) | Babesia microti 2D97 antigen protein and application thereof | |
JP4830106B2 (en) | Trichinella species-specific antigen and method for testing Trichinella infection using the antigen | |
CN111273005B (en) | Enzyme linked immunosorbent assay kit and method for detecting toxoplasma gondii IgG antibody | |
CN114031679A (en) | Cryptosporidium oocyst wall outer wall marker protein for detection and application thereof | |
CN109371043B (en) | Babesia microti 2D33 and 2D36 antigen proteins and application thereof | |
CN110357951B (en) | Schistosoma japonicum immune epitope recombinant protein and application thereof | |
CN114106158B (en) | Nanometer antibody targeting porcine pseudorabies virus gD protein, preparation method and application | |
CN110423270B (en) | Preparation of Toxoplasma gondii surface antigens GRA1 and GRA7 recombinant protein | |
CN109678952A (en) | A kind of polyclonal antibody based on Wheat Yellow strip virus G-protein, preparation method and applications | |
CN114524869B (en) | Toxoplasma microwire protein MIC17a and application thereof | |
AU2020101749A4 (en) | Recombinant protein for rapid detection of Toxoplasma gondii, preparation method and use thereof | |
KR100536848B1 (en) | Kit for Diagnosis of Foot-and-Mouth Disease Containing Peptide of 2C and 3B Nonstructural Protein of Foot-and-Mouth Disease Virus | |
CN116559441A (en) | Application of TGME49_229320 protein in preparation of toxoplasmosis diagnosis kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210312 |